Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 May;13(5):270-2.
doi: 10.1038/nrclinonc.2016.59.

Targeted therapy: Generic imatinib - impact on frontline and salvage therapy for CML

Larry Gorkin  1 , Hagop Kantarjian  2
Affiliations
Comment

Targeted therapy: Generic imatinib - impact on frontline and salvage therapy for CML

Larry Gorkin et al. Nat Rev Clin Oncol. 2016 May.

Abstract

Imatinib has revolutionized the treatment of chronic myeloid leukaemia (CML). In 2016, generic imatinib will be introduced into the US market. We analyse the potential impact of this new product on patient care and optimal CML therapy, and comment on the effect that distorted cancer drug pricing in the USA will have on treatment for patients with limited therapeutic options.

PubMed Disclaimer

Conflict of interest statement

Competing interest statement

FURTHER INFORMATION

Truven Health Analytics RED BOOK: http://micromedex.com/products/product-suites/clinical-knowledge/redbook

Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch–Waxman Amendments): http://www.fda.gov/newsevents/testimony/ucm115033.htm

Comment on

References

    1. Novartis Q4 and FY 2015 Condensed Financial Report. 2016 Jan; Retrieved from https://www.novartis.com/investors/financial-data/product-sales.
    1. Sun hopes cut-price generic Gleevec will win third of U.S. market. 2016 Feb; Retrieved from http://www.reuters.com/article/sun-gleevec-genericdrugs-idUSKCN0VA3M9.
    1. Padula WV, Larson RA, Dusetzina SB, et al. Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States. J Natl Cancer Inst. 2016 Mar; doi: 10.1093/jnci/djw003. - DOI - PMC - PubMed
    1. Chhatwal J, Mathisen M, Kantarjian H. Are High Drug Prices for Hematologic Malignancies Justified? A Critical Analysis. Cancer. 2015;121(10):3372–9. - PubMed
    1. Evaluating the value of new drugs. 2015 Jul; Retrieved from http://www.icer-review.org/wp-content/uploads/2014/01/ICER-value-assessm....

MeSH terms